Background: Human immunodeficiency virus type 1 (HIV-1) is the etiologic agent of acquired immunodeficiency virus (AIDS). Following entry into the host cell, the viral RNA is reverse transcribed into DNA and subsequently integrated into the host genome as a chromatin template. The integrated proviral DNA, along with the specific chromatinized environment in which integration takes place allows for the coordinated regulation of viral transcription and replication. While the specific roles of and interplay between viral and host proteins have not been fully elucidated, numerous reports indicate that HIV-1 retains the ability for self-regulation via the pleiotropic effects of its viral proteins. Though viral transcription is fully dependent upon host cellular factors and the state of host activation, recent findings indicate a complex interplay between viral proteins and host transcription regulatory machineries including histone deacetylases (HDACs), histone acetyltransferases (HATs), cyclin dependent kinases (CDKs), and histone methyltransferases (HMTs).
Background
Human immunodeficiency virus (HIV) is the etiological agent of AIDS. The pathogenesis of HIV-induced disease is complex and multifactorial [1] . Following infection, reverse transcriptase complexes synthesize a double stranded DNA molecule that is then incorporated into the host genome. A robust cellular and humoral immune response inhibits viral production within weeks. However, a chronic persistent infection in lymphoid tissue persists throughout the life (median period of 10-20 years) of the infected individual. Several key HIV-1 and cellular proteins have been determined to be necessary for this course of infection, including the trans-activator Tat. Viral clones deficient in Tat do not effectively replicate in vitro or in vivo. Furthermore, infected T cells quiescent at the G 0 phase of the cell cycle (lacking cytokine signals) will not produce high titer virus [2] .
The replication rate of integrated HIV-1 is largely controlled at the level of transcription. The HIV-1 LTR, present at both ends of the integrated viral genome, contains cis-acting elements necessary for transcription initiation from the 5' LTR and for polyadenylation of the viral transcripts in the 3' LTR. The core promoter of HIV-1 includes two NF-κB binding sites, three Sp1 binding sites, the TATA box, and the ligand-binding protein 1 (LBP-1)/YY1 site. There is also a repressor complex sequence (RCS) within the initiation site, which contains three binding motifs for LSF. YY1 and LSF cooperate to allow binding of YY1 to the RCS and subsequent recruitment of HDAC1 [3] . In addition to cellular transcription factors, the activity of the HIV-1 promoter is strongly dependent on the viral transactivator, Tat. Historically, the mechanism of action by Tat has been assigned to be at the level of initiation and elongation [4] [5] [6] [7] [8] [9] . The effect of Tat on pre-initiation, initiation, and elongation has been observed through a number of biochemical interactions, including physical binding to Sp1 [10] , stabilization of the TFIID/TFIIA complex on the HIV-1 TATA box [11] , recruitment of a functional TATAbinding protein (TBP) or TFIID [11] [12] [13] [14] [15] [16] , phosphorylation of the carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII) by a number of kinases, including TFIIH [17] [18] [19] , hSpt5 which functions in transcription elongation as a stabilization factor of RNAPII [20] , and binding of Tat directly to RNAPII [21, 22] . More recently the role of Tat in transcription initiation has been revisited, where Tat enhanced recruitment of TBP has been observed resulting in activated transcription [23, 24] .
Tat activates the HIV LTR by binding to TAR and recruiting and activating cellular factors [25] [26] [27] [28] [29] [30] [31] . One of the co-factors required for Tat activity is a protein kinase called TAK (Tat-associated kinase) [32, 33] whose activity is stimulated by Tat. Activation of TAK (cdk9/cyclin T 1 ) results in hyper-phosphorylation of the large subunit of the RNAPII CTD and activation of transcription elongation [34] . Cdk9 is analogous to a component of a positive acting elongation factor (P-TEFb) isolated from Drosophila [35] , which acts to stimulate promoter-paused RNAPII to enter into productive elongation [33, [36] [37] [38] [39] . A histidine-rich stretch of cyclin T 1 binds to the CTD of RNAPII, which is required for the subsequent expression of full-length transcripts from target genes [40] . Cdk9 phosphorylation is required for high-affinity binding of Tat/P-TEFb to TAR [41] [42] [43] .
HIV-1 proviral DNA is organized into a higher order chromatin structure in vivo, which regulates viral expression by restricting access of the transcriptional machinery to the HIV-1 LTR. The primary chromatin structure of integrated HIV-1 has been characterized in vivo by the DNase-1 digestion method [44] [45] [46] . Two chronically infected human cell lines, ACH 2 (T-cell line) and U 1 (promonocyte cell line), were analyzed by DNase-I digestion and four distinct DNase-I hypersensitive sites (DHS) were identified in the 5' LTR. It has been largely assumed that DHSs in the native chromatin are free of histones and allow unrestricted access to DNA-binding proteins [47] . The first site, DHS1, located at the 5' end of the integrated LTR, was detected only as a minor DHS in U 1 cells. DHS2 and DHS3 are located in the U3 region, encompassing nt 223-325 and nt 390-449, respectively. The NF-κB and Sp1 binding sites, as well as the TATA box, are located in DHS2 and DHS3. DHS4 was found immediately downstream of the U5 region (nt 656-720), where a cluster of potential transcription factor binding sites for AP-1, AP-3 like, DBF-1, and Sp1 are positioned. The location of the DHSs was also verified in vitro using the HIV-1 promoter reconstituted into chromatin by DNase-I footprinting analysis [48] [49] [50] . Furthermore, independent of the viral integration site, five nucleosomes (nuc-0 to nuc-4) are precisely positioned within the 5' LTR. In the transcriptionally silent provirus, these nucleosomes define two large nucleosome-free regions spanning nt -255 to -3 and +141 to +265. One nucleosome, nuc-1, is located between these two regions. The first nucleosome-free region in U3 contains many promoter/enhancer elements which are already occupied by transcriptional factors including repressors [51] . When cells are activated with TNF-α and TPA treatment or with the HDAC-specific inhibitors, trapoxin, Trichostatin A (TSA), or sodium butyrate, DHS3 and DHS4 are extended and nuc-1 is specifically remodeled. Using a ChIP assay, histone acetylation surrounding nuc-1 and the RCS was observed to be significantly increased following TSA treatment [52] . The disruption of nuc-1 occurred independent of transcription and was α-amanitin insensitive, suggesting that this chromatin remodeling was a pre-requisite for transcription, rather than a consequence [46] . Therefore, the integrated proviral DNA, along with the specific chromatinized environment in which integration takes place allows for the coordinated regulation of viral transcription and replication. While the specific roles of and interplay between viral and host proteins have not been fully elucidated, numerous reports indicate that HIV-1 retains the ability for self-regulation via the pleiotropic effects of its viral proteins. Though viral transcription is fully dependent upon host cellular factors, recent findings indicate a complex interplay between viral proteins and host transcription and signaling machineries (i.e. HDACs, HATs, and other protein-modifying factors).
In the current manuscript, we describe the effect of Tat activated transcription at the G 1 /S border of the cell cycle and analyze the interaction of Tat with the chromatin remodeling complex, SWI/SNF. HIV-1 LTR DNA reconstituted into nucleosomes can be activated in vitro using various Tat expressing extracts. More specifically, optimal activated transcription was observed at the G 1 /S border of the cell cycle both in vitro and in vivo. In an attempt to define protein complexes that are normally involved in HIV-1 transcription, we used an in vitro immobilized nucleosomal DNA assembly system in the presence of the G 1 /S extracts and pulled-down complexes followed by their identification using MALDI-TOF mass spectrometry. In addition to known factors such as Sp1, TFIIB, and cdk9/ cyclin T 1 , we also specifically detected the presence of acetylated Tat and members of the SWI/SNF chromatin remodeling complex. Using a number of in vitro binding as well as in vivo ChIP assays, we detected the presence of both BRG1 and acetylated Tat in the same complex. Finally, we demonstrate that removal of nuc-1 resulted in accessibility of the HIV-1 LTR DNA to a restriction enzyme and activated transcription.
Results

Effect of Tat activation at the G 1 /S border
We previously demonstrated, by in vitro transcription analysis, that Tat-dependent transcription takes place in a cell cycle-dependent manner. We utilized cells that were transfected with either a control plasmid (pCEP4) or a hemagglutinin epitope-tagged Tat plasmid (eTat), selected in hygromycin by single-cell dilution, and maintained in hygromycin. Whole-cell extracts were prepared from control and eTat cells for in vitro transcription assays using wild-type and mutant HIV-1 naked templates. Cells at late G 1 /early S contained 10-fold higher levels of transcriptional activity on the wild-type LTR template (LTR-TAR + ) than on the TAR mutant template (LTR-TAR -) [53] .
Our previous results were performed with HIV-1 naked LTR DNA; however, in vivo, the HIV-1 DNA is assembled into organized nucleosomal DNA and the presence of nucleosomes generally acts as an inhibitor of transcription. Therefore, to closely mimic the in vivo scenario, we decided to reconstitute HIV-1 LTR DNA into nucleosomes and use the templates in an in vitro transcription reaction. Nucleosomes were assembled on the HIV-1 LTR as previously described [48, 54, 55] . Following reconstitution, extracts from various stages of cell cycle were used in an in vitro transcription reaction. To obtain a uniform population of cells, we treated both eTat and control cells first with hydroxyurea, released, treated with nocodazole, followed by release at various time points. Extracts were made from the control and eTat cell lines at G 0 , early G 1 , G 1 /S, late S, and G 2 for in vitro transcription. Three types of DNA were used in these assays, including HIV-LTR-TAR wild-type, HIV-LTR-TAR mutant (TM26) (both assembled into chromatin) and Adenovirus-Luc plasmid (AdLuc) as a naked DNA control [55] . Transcription from the WT HIV LTR was first observed with eTat extracts purified from the G 1 phase (Figure 1 , left panel, lane 2). Transcription was maximal at the G 1 /S border and declined during the S and G 2 phases (lanes 4 and 5). Very little detectable transcription was observed with extracts obtained at the G 0 (lane 1) or in control extracts. Furthermore, no transcription was observed when a TAR mutant template (TM26) was used (lanes [11] [12] [13] [14] [15] . These results indicate that HIV-1 transcription started in the early G 1 phase (lane 2); however, a more robust activity was observed at the G 1 /S border (lane 3). In all cases ample transcription was observed using naked AdLuc DNA. All HIV-1 DNAs still contained core histones after transcription, indicating that nucleosomes were still present (bottom panel). These results indicate that robust Tat activated transcription begins at the G 1 /S border of the cell cycle.
Presence of HIV-1 transcripts at the G1/S border in infected cells
To determine the timing of HIV-1 transcription, we measured the accumulation of two HIV-1 proteins (Nef and Env), as well as cyclin E and cyclin A (positive controls) in OM10.1 cells during various stages of the cell cycle. We measured these proteins by a multiparametric flow cytometric approach [56] . This technique allowed us to examine the accumulation of multiple proteins in individual cells, as opposed to immunoblotting, which determines the accumulation of proteins in a large, diverse cell population. Furthermore, the flow cytometric approach allows us to correlate this value with respect to the cell's position in the cycle by measuring DNA content and multiple analyses can be carried out in the same cell with different fluorescent markers. OM10.1 cells are a promyelocytic line containing a transcriptionally latent, single copy of wildtype HIV-1 integrated proviral DNA [57] . For cell cycle analysis, these cells were initially arrested at G 0 by feeding with serum starvation medium for three days. Cells were subsequently treated with TNF-α (10 ng/ml) for 2 h to induce virus, washed, and incubated at 37°C with complete medium. Samples (2/3) were collected at various time points and analyzed using flow cytometry. The remaining samples (1/3) were processed for RT-PCR using primers for Env and Nef [58, 59] . The positive controls, cyclin E (hallmark of G 1 /S transcription) and cyclin A (hallmark of S transcription), were detectable in OM10.1 cells ( Figure 2A ). More importantly, HIV-1 proteins, namely Nef (from a doubly spliced transcript) and Env (from a singly spliced transcript), were detected starting at the G 1 /S phase of the cell cycle. RT-PCR assays show that these samples display robust Env transcription at the G 1 /S border ( Figure 2B ) demonstrated that the samples used in Figure 2A were at particular phases of the cell cycle. These results are also consistent with our previous work where we showed that HLM-1 cells (HIV-1 + /Tat -, [60] ), which contain a single copy of full-length HIV-1 provirus with a triple termination codon at the first AUG of the Tat gene, had dramatically reduced levels of Gag/p24 antigen production when arrested at G 1 /S [61] .
Presence of chromatin remodeling factors on HIV-1 DNA at the G 1 /S border
To define some of the protein complexes that are normally involved in HIV-1 transcription, we utilized an in vitro nucleosomal DNA assembly system, where the DNA was labeled with biotin and bound to strepavidin beads [62] . Subsequently, G 1 /S extracts were mixed with the nucleosomal DNA and unbound material was washed away. Retained complexes were separated on a 4-20% SDS/PAGE and unique bands were used for MALDI-TOF mass spectrometry ( Figure 3 ). Four clade B LTR promoters (nt -110 to +180) were used as controls, HXB 2 , pNL43, LAI, and SF2. Also, nucleosomal templates were either transcriptionally inactive (no nucleotides) or were transcriptionally active with three nucleotides added to the reaction (ATP, CTP, and GTP). In the latter case, the polymerase normally stalls at the early stages of elongation. As a further set of controls, we utilized the clade B LTR of wild-type, TATA + /TAR -, TATA -/TAR + , and AdML promoters [53] .
A limited number of proteins bound to the transcriptionally inactive control promoters including histones H4, H2A, H2B, and H3 ( Figure 3A 
HIV-1 Nef and Env expression in individual cells at various phases of the cell cycle Figure 2 HIV-1 Nef and Env expression in individual cells at various phases of the cell cycle. A)
HIV-1 protein expression was monitored by flow cytometric analysis. OM10.1 cells were washed in Hanks' balanced salt solution, fixed in 70% ice-cold ethanol, and stained with mouse anti-human monoclonal antibodies to cyclin E, cyclin A, Nef, Env, or a non-specific immunoglobulin (DAKO) overnight. Cells in G 1 and G 2 were identified by DNA content and divided the intervening region into 10 to 12 equal increments to allow the calculation of mean protein-associated fluorescence and mean DNA content. The exact same analysis was performed on the appropriate aliquot stained with non-specific immunoglobulin. Protein fluorescence was determined by subtracting the mean from the nonspecific samples. Samples were washed in PBS-BSA and stained with a fluorescein isothiocyanate-labeled goat anti-mouse secondary antibody (1:30; DAKO) for 30 min in the dark. The bottom of panel A shows HIV-1 gene expression in G 0 , early G 1 , G 1 /S, S, and G 2 phases of cell cycle by RT-PCR with primers for Env and Nef [58, 59] . B) Cell cycle analysis of cells after G 0 release. Cells were synchronized at G 0 by serum starvation and samples were removed from the medium at each time point, washed with PBS without Mg 2+ or Ca 2+ , fixed with 70% ethanol, and stained with propidium iodide followed by cell-sorting analysis on a Coulter EPICS cell analyzer. The FACS profile for each time point is presented along with the percentage of cells in G 1 , S, and G 2 (upper right side boxes of each histogram). TATA -/TAR + , HXB 2 TATA + /TAR -, and AdML promoters ( Figure 3B ). A number of unique proteins were bound to the wild-type promoter that were not bound on the HXB 2 TATA -/TAR + and TATA + /TARpromoters (data not shown). Results in Figure 3A confirms published data showing that TFIIB, cdk2, cdk9, cyclin E, cyclin T 1 , Sp1, RNAPII, and DNA-PK associate with the HIV-1 LTR during basal transcription or Tat activated transcription. These results also showed that cdk9/cyclin T 1 and other cyclin/cdk complexes (i.e. cdk2/cyclin E) are involved in transcription of the HIV-1 promoter. Finally, these results indicate that Tat recruits a component of the chromatin remodeling complex, BRG1, to the HIV-1 LTR.
Effect of acetylated Tat on recruitment of a chromatin remodeling complex
The identification of BRG1 as one of the proteins that bound to transcriptionally active HIV-1 LTR suggests that this component of the SWI/SNF complex may be important in Tat activated transcription. To elucidate the role of Identification of cellular proteins associated with the transcriptionally active nucleosomal HIV-1 promoter
Figure 3 Identification of cellular proteins associated with the transcriptionally active nucleosomal HIV-1 promoter. A)
Nucleosomes were assembled on biotin labeled HIV-1 LTR DNA and G 1 /S extracts were added to the reaction mixture. Following washes (TNE 600 plus 1% NP-40), samples were eluted with excess biotin and centrifuged to pellet the beads. Supernatants were TCA precipitated and ran on a 4-20% gel and silver stained (MALDI compatible To determine whether these complexes bind HIV-1 DNA, we utilized an in vitro transcription/assembly system [62] , where HIV-1 proviral LTR DNA was assembled into nucleosomal DNA prior to in vitro transcription. Nucleosomes were first assembled on biotinylated HIV-1 LTR DNA tem-plate and then immobilized using strepavidin agarose beads. The immobilized chromatin LTR was washed in acetylation buffer and used as a substrate for acetylation by p300 in the presence or absence of Tat. Templates were then washed in transcription buffer and used in an in vitro run-off transcription reaction. Active complexes were pulled-down, washed, ran on a 4-20% SDS/PAGE, stained for the presence of histones and then western blotted for the presence of cyclin T 1 or BRG1. Results in Figure  4D indicate that the wild-type Tat acetylated by HAT was able to efficiently bind to BRG1, consistent with results from panel B, where there was no HIV-1 DNA present in the reaction. Finally, to address whether these interactions were functionally significant in a chromatin transcription setting, we utilized the G 1 /S extract from CEM cells in an in vitro transcription reaction. Similar to HeLa cells (data not shown), CEM cells were treated with hydroxyurea/ nocodazole, and samples were processed at 9 h postrelease (G 1 /S) for in vitro transcription. The extracts were supplemented with SWI/SNF (all lanes), plus wild-type Tat (lanes 2 and 6), acetylated Tat (lanes 3 and 7) , and mutant Tat (50/51) (lanes 4 and 8) . Naked AdLuc DNA served as an internal control for transcription. As can be seen in Figure 4E , only acetylated Tat allowed for a robust transcription from the wild-type LTR (lane 3) and not the mutant TAR template (lane 7). Furthermore, addition of anti-acetyl Tat 50/51 antibodies (see Figure 5 ) at increasing concentrations (panel E, 100, 300, and 500 ng; lanes 10-12) specifically inhibited transcription from the HIV-1 template. Collectively, these results indicate that acetylayted Tat has a high affinity to BRG1, and a combination of both Tat and BRG1 (SWI/SNF) promote TAR-specific HIV-1 transcription.
Presence of acetylated Tat and BRG1 on HIV-1 nucleosomal DNA in vivo
To assess the functional relevance of Tat acetylation in vivo, we performed a series of ChIP assays from HIV-1 infected cells. We first raised polyclonal antibodies against acetylated Tat using acetylated Tat peptides as antigens. These antibodies recognize Tat acetylation at lysine 41 or 50 and 51. Next, we transfected HLM-1 cells with a wildtype Tat plasmid (eTat). These cells are HIV-1 + /Tat -, thus introduction of wild-type Tat allows for full trans-activation and viral progeny formation. When anti-acetyl-Tat antibodies were used for immunoprecipitation, we consistently observed an association of acetylated Tat at regions where nuc-1 is located but not nuc-0 ( Figure 5 ). These data suggest that Tat is acetylated in vivo and is associated with the nuc-1 region of the HIV-1 promoter, which encompasses the transcription start site.
Effect of BRG1 on HIV-1 transcription in vivo
Tat recruitment of SWI/SNF to the HIV-1 LTR presumably plays a role in the ability of Tat to trans-activate the pro- moter and induce replication. To assess this possibility, RNA interference (RNAi) of BRG1 expression in HIV-1 infected cells was used. Here, we synthesized a series of wild-type and mutant siRNA against BRG1. We chose five oligonucleotides that span the 5' end, middle, and 3' end of the BRG1 mRNA. The sequences of the siRNA and the nucleotide position are listed in Materials and Methods and have previously been published [74] . The most optimal sequences had a GC content of between 30%-70% [74] . To assess the importance of BRG1 in viral transcription, we utilized the HIV-1 chronically infected cell ACH 2 . Viral induction in ACH 2 cells was achieved by treatment with TNF-α ( Figure 6 , left panel). Addition of increasing amounts of wild-type BRG1 siRNA (a mixture of all five oligonucleotides electroporated into cells) resulted in a decrease in p24 expression. However, when mutant BRG1 siRNA was utilized, p24 expression and, hence HIV-1 progeny formation, was unaffected. Similar results were obtained in other chronically infected cells including OM10.1, 8E5 ( Figure 6 , right panels), and J1-1 as well as U 1 (data not shown). BRG1 protein expression was also decreased as a result of the siRNA (wild-type) treatment; Acetylated Tat associates with a chromatinized HIV-1 promoter at or near nuc-1 but not nuc-1 
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mutant siRNAs did not affect BRG1 protein levels ( Figure  6, bottom panel) . These results indicate that BRG1 expression is critical for HIV-1 replication.
Next, we investigated whether BRG1 was in fact recruited to the HIV-1 promoter in vivo. We transfected a BRG1 eukaryotic expression construct [74] into C33A cells that had an HIV-1 reporter construct stably integrated into its genome [75] . Cells were either left untreated, stimulated with PMA, treated with the HDAC inhibitor TSA, or exposed to both PMA and TSA. Following harvesting, a ChIP assay was performed with antibodies against BRG1. Immunoprecipitated DNA was analyzed by PCR with primers specific for nuc-0 and nuc-1. Figure 7A shows that BRG1 does interact with the nuc-0 region in vivo and that this interaction is dependent upon presence of both PMA and TSA (panel A top, lanes 7 and 11) . The presence of BRG1 on nuc-0 was not Tat dependent (lanes 8-10). However, BRG1 was present on nuc-1 in the presence of PMA or TSA (panel A bottom, lanes 5, 6, 9, and 10). More importantly, BRG1 was present on nuc-1 in unstimulated cells in the presence of Tat (compare lanes 4 and 8) . A Tat 50/51 mutant did not recruit BRG1 to the nuc-1 site (data not shown). Finally, since BRG1 is recruited to the nuc-1 region of the HIV-1 promoter in response to Tat expression alone, we investigated whether this recruitment stim- Figure 6 Suppression of BRG1 expression by RNAi inhibits HIV-1 replication. Complete sequence of BRG1 wild-type and mutant siRNA used in transfection. Oligos were designed and synthesized using the OligoEngine website [109]. HIV-1 infected cells (ACH 2 , OM10.1 and 8E5) were treated with TNF-α (10 ng/ml) for 2 h, washed, and subsequently electroporated (ACH 2 , [113]) or Amexa (OM10.1 and 8E5) treated with increasing amounts (1, 5, or 10 μg) of either wild-type (WT) or mutant (mut) BRG1 siRNA. Forty eight hours later, samples were collected and used for p24 gag ELISA. Western blot against BRG1 showed more than 90% decrease in protein levels in WT and not mutant BRG1 siRNA transfect cells [74] . , before ChIP. A ChIP assay was performed with BRG1 antibodies, and PCR was used to detect the recovery of nuc-0 and nuc-1 DNA. The input DNA represents the total genomic DNA. Ab, antibody; Unstim, unstimulated. B) BRG1 and Tat were transiently expressed in C33A cells that had been stably transfected with an HIV-1-luciferase construct. Thirty-six hours after transfection, cells were stimulated with either PMA for 2 h, TSA for 12 h, or both for 12 h. Following stimulation, cells were lysed, and the luciferase activity was measured [114] . Data presented is from average of two individual experiments. A) ulated transcription. C33A cells containing a stably integrated HIV-1 luciferase reporter construct were transiently transfected with the BRG1, Tat, or BRG1 and Tat expression constructs or a control vector (Mock). Figure  7B shows that without BRG1 or Tat; PMA, TSA or PMA and TSA stimulated HIV-1 luciferase transcription anywhere from 3-to 14-fold. However, in the presence of both Tat and BRG1 the stimulation increased from 28-to 89-fold above background, implying that to recover robust activated transcription, the integrated HIV-1 promoter requires both Tat and BRG1. This also indicates that a factor required for a high level of HIV-1 reporter expression is limiting in C33A cells. Hence, we concluded that Tat acetylation, followed by BRG1 recruitment, plays an important role in stabilizing the interaction between SWI/ SNF and HIV-1 chromatin resulting in remodeling of nuc-1 and activated viral transcription.
Suppression of BRG1 expression by RNAi inhibits HIV-1 replication
- + - - - - - - - - - - - - - - - BRG-1 (siRNA, mut) - - - - - - - - - - - - - - BRG-1 (siRNA, WT) + + + + + + + - + + + + + + + - + + + + + + - TNF - + - - - - - - - - - - - - - - - BRG-1 (siRNA, mut) - - - - - - - - - - - - - - BRG-1
Effect of BRG1 and acetylated Tat on nucleosomes on the HIV LTR
A number of investigators, including the Verdin lab, have performed pioneering experiments to define the nucleosome positions in HIV-1 infected cells. The HIV-1 genome was first analyzed for the presence of DNase-I hypersensitive sites using an indirect end-labeling technique [45] . Three well characterized, chronically infected cell lines, ACH 2 , 8E5, and U 1 , were used to define nucleosome boundaries. Five major hypersensitive sites were identified, some of which were common among the three cell lines. They included DNase-I hypersensitive sites at the 5' LTR, namely HS2 (nt 223-325), HS3 (nt 390-449), and HS4 (nt 656-720) [46] . Both HS3 and HS4 are at the 5' and 3' boundaries of nucleosome-1 (nuc-1), respectively. Nuc-1 is located at the transcriptional start site and poses a block to activated transcription [76] . However, when activated transcription occurs, there is a disappearance of the periodic DNA protection pattern following digestion with DNase-I and reveals a profile of digested template essentially identical to naked DNA [46] . Therefore, nuc-1 is disrupted when activated transcription takes place in all three cell lines tested [45, 46, [76] [77] [78] [79] [80] .
We then determined whether BRG1 and/or acetylated Tat are responsible for removing nuc-1, and whether we could faithfully mimic the in vivo data in an in vitro remodeling assay. We used two LTR sequences spanning 800 bp from the 5' U3 region into the Gag region. Sequences from clades B and E were PCR amplified with biotin-labeled primers, assembled into nucleosomes, and mixed with CEM G 1 /S extracts for in vitro transcription. To facilitate chromatin remodeling, we also added SWI/SNF, Tat, or acetylated Tat to the reaction. Following transcription, immobilized templates were pulled-down, washed, and used for restriction enzyme digestion (Afl II). Afl II cleaves at position 520 at the end of the R (TAR) region. The Afl II site is normally blocked if nuc-1 is present; however, the site becomes accessible if the nucleosome is remodeled or removed. Therefore, if Afl II is able to cleave the DNA, then a 3' fragment consisting of U5 and Gag will be released into the supernatant and the fragment can be detected by Southern analysis using a probe spanning the U5/Gag region. A diagram of the experiment is illustrated in Figure 8A while the results are shown in Figure 8B . 
Discussion
The chromatin structure presents a significant barrier to transcription. Various complexes, including HATs, covalently modify nucleosomal histone proteins through acetylation while ATP-dependent chromatin remodelers alter the chromatin structure via ATP hydrolysis. These modifications and alterations of chromatin structure increase DNA accessibility to transcription factors and activators thus promoting transcription initiation and efficient elongation. A more current view is that activators must first recruit chromatin remodelers in order to create a chromatin environment permissive for pre-inititation complex (PIC) assembly. Recently, it has become evident that other factors, such as the chromatin structure of the gene promoter and the phase of the cell cycle, also govern how chromatin remodelers collaborate with each other to control steps before, during, or after PIC assembly.
Although the precise nucleosome position of the integrated HIV-1 LTR is well characterized, there is little data about how this primary structure is folded into the chromatin fiber or other secondary structures (>30 nm fiber) and how these structures influence HIV-1 latency and transcriptional activation. Few studies have shown that the integration site and its corresponding chromatin environment affect HIV-1 gene expression [81, 82] . Sequence analysis and mapping of HIV-1 integration sites in the cel- 
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lular genome has provided evidence that chromatin structure plays an important role in subsequent HIV-1 transcription. Analysis of the site of integration during productive HIV-1 infection has shown that integration preferentially occurs in areas rich in retrotransposable Alu elements [83] [84] [85] and transcriptionally active genes (69% of 524 integration sites) [83] . These areas are characterized by increased chromatin accessibility and the accumulation of factors important for chromatin remodeling. These data are also consistent with earlier observations that sites which are preferentially accessible to DNase-I are favored for integration [86] [87] [88] [89] . However, a small fraction of cells (less than 1%) exhibited post-integration latency, a state of transcriptional silencing.
Many reports in the last several years have linked Tat transactivation to chromatin remodeling in vitro and in vivo. When transcription is activated by Tat in a LTR integrated cell line, the chromatin associated with sequences immediately downstream of the transcription start site become accessible to nucleases and the nucleosome adjacent to the transcription start site (nuc-1) becomes disrupted [78] . Similarly, transfection of Tat into Jurkat (Tat -) clones containing a integrated single HIV-1 mini-genome activated HIV-1 transcription and resulted in the disruption of nuc-1 to the same extent as TSA treatment [82] . Furthermore, immunoprecipitation of Tat from human cells identified a protein complex with HAT activity, suggesting that HATs are targeted to the HIV-1 promoter by Tat [90] . Interestingly, in vitro transcription from chromatinized templates indicated that Tat trans-activation is synergistic with Sp1 and NF-κB [48] . In vivo, HIV-1 LTR lacking Sp1 and NF-κB sites do not undergo chromatin remodeling and are unresponsive to Tat trans-activation [78] . Several other groups have observed that Tat is able to form a ternary complex with several HAT complexes, including p300/CBP, p/CAF, TAFII250, and Tip60, targeting these HAT proteins to the viral promoter [70, [90] [91] [92] [93] [94] .
Similar to our findings, two recent reports have shown the involvement of SWI/SNF as a cofactor for Tat activation of the HIV promoter. Tréand et al. [95] showed that, via its arginine-rich motif, Tat It is interesting to note that INI-1 (Snf5/BAF47) is also a potent tumor suppressor whose mechanism of action is largely unknown. Tumor suppressor activity of Snf5 depends on its regulation of cell cycle progression; Snf5 inactivation leads to aberrant up-regulation of E2F targets and increased levels of p53 that are accompanied by apoptosis, polyploidy, and growth arrest. Furthermore, conditional mouse models demonstrate that inactivation of p16Ink4a or Rb does not accelerate tumor formation in Snf5 conditional mice, whereas mutation of p53 leads to a dramatic acceleration of tumor formation [98] . Therefore, it would be interesting to further determine if the binding of Tat to the SWI/SNF complex (either through INI-1 or BRG1) could somehow control the expression of cell cycle genes (i.e., G 1 /S genes) and alter their activity. Current experiments are in progress to address this critical issue and whether G 1 /S genes such as various cyclins, including the cyclin E and T promoters, are modulated by the Tat/SWI/SNF complex.
We and others have shown that Tat can be acetylated at lysines 28, 50, and 51 leading to altered interactions between Tat and TAR, p300/CBP, and p/CAF, as well as activation of viral transcription and replication. They collectively support the notion that Tat first recruits p300/ CBP to the HIV-1 promoter during initiation. Tat acetylated at lysine 50 then recruits p/CAF, which subsequently acetylates Tat at lysine 28. Acetylation of Tat at lysines 50 and/or 51 promotes the dissociation of Tat from TAR RNA and contributes to stimulation of transcription elongation [60, 99] . The acetylated form of Tat is released from TAR, which can now bind to BRG1, a component of the SWI/SNF chromatin remodeling complex. We hypothesize that the interaction of Tat with BRG1 facilitates SWI/SNF to remodel downstream nucleosomes allowing for further transcription of the HIV-1 genome. We propose that the major function of the interactions between Tat and bromodomain proteins is to modify HIV-1 chromatin such that the LTR becomes responsive to Tat and allows ample and rapid activated transcription to occur. This also may set the stage for re-initiation of transcription where pre-made (activated) complexes may be recycled for HIV-1 activated transcription. Future experiments will address these particular issues along with Tat's effect on the remodeling activity of the SWI/SNF complex at the proximal promoter and ORF regions of HIV-1 genome.
Materials and methods
Cell culture ACH 2 and 8E5 cells are both HIV-1-infected lymphocytic cells, with a single integrated wild-type copy (ACH 2 ) and a single integrated copy containing a defective reverse transcriptase (8E5) in CEM (12D7) cells. The CEM T cell (12D7) is the parental cell for both ACH 2 and 8E5 cells. U 1 is a monocytic clone harboring two copies of the viral genome from parental U973 cells. All cells were cultured at 37°C with up to 1 × 10 5 cells per ml in RPMI 1640 media containing 10% fetal bovine serum (FBS), 1% streptomycin/penicillin antibiotics, and 1% L-glutamine (Gibco-BRL, Carlsbad, CA). HLM-1 cells (AIDS Research and Reference Reagent Program, Catalog No. 2029) were derived from HeLa-T41 cells integrated with one copy of the HIV-1 genome containing a Tat-defective mutation. The mutation was introduced as a triple termination linker at the first AUG of the Tat gene. HLM-1 cells are completely negative for virus particle production, but can be induced to express one cycle of infectious HIV-1 particles after transfection with Tat cDNA or mitogens such as TNF-α or sodium butyrate. HLM-1 cells were grown in DMEM containing 10% FBS, 100 mg/ml of G418, plus 1% streptomycin/penicillin, and 1% L-glutamine (Gibco BRL). Cells were grown to 75% confluency prior to the transfection. Plasmids were transfected into HLM-1 cells by electroporation or Amexa, washed after 4 h, and re-fed with fresh complete DMEM with 10% FBS for the remainder of the experiment.
Generation of epitope-tagged Tat-expressing cell line
HeLa CD4 + cells were used for transfection with either an epitope-tagged (the influenza epitope at the C-terminus of Tat 1-86) plasmid or the parental vector pCEP4. Following transfection, cells were selected with 200 μg of hygromycin/μl. Hygromycin-resistant lines established from single-cell clones were maintained for up to 12 months with continuous passage and used to make extracts for in vitro transcription analysis [53] .
ChIP assays
Five to ten million infected cells in log phase were incubated for 2 h with or without 5 μg/ml TNF-α to induce transcription of latent proviral DNA. Cells were subsequently left untreated or treated with siRNA. After 48 h, cells were cross-linked (1% formaldehyde, 10 min at 37°C) and samples were sonicated to reduce DNA fragments to 200-800 nt lengths for ChIP assays. Specific transcription complexes were immunoprecipitated with appropriate antibodies. DNA sequences in the immunoprecipitates were detected by PCR using primers specific for the HIV-1 LTR (forward primer, 5'-ACTTTTCCG-GGGAGGCGCGATC-3'; reverse primer, 5'-GCCACT-GCTAGAGATTTCCACACTG-3') or Env region (forward primer, 5'-CCTTG(T)GAGCCAATTCCCATA-3'; reverse primer, 5'-TAACAAATGCTCTCCCTGGTC-3').
MALDI-TOF analysis
Individual protein bands were excised from the silverstained gel and destained with a solution of 30 mM potassium ferricyanide/100 mM sodium thiosulfate (1:1) (v/v). Trypsin-digested sample solutions were further desalted and concentrated with C 18 ZipTips (Millipore, Framingham, MA). Samples were mixed with the same volume of the matrix solution (α-cyano-4-hydroxycynnamic acid in 50% acetonitrile/0.1% [v/v] trifluoroacetic acid). Two microliters of the mixtures were applied to the sample plate and introduced into the mass spectrometer after drying. Mass spectra were recorded in the reflectron mode of a MALDI-TOF mass spectrometer (Voyager-Elite; PerSeptive Biosystems) by summing 200-300 laser shots with an acceleration voltage of 20 kV, 70% grid voltage, 0.05 guide wire voltage, 100 ns delay, and low mass gate at 700 m/z. Proteins were identified using the peptide mass fingerprinting analysis software ProFound [101]. The NCBInr database was used for the searches with several passes of searching with different limitations for each spot. In general, all bands were searched using methionine oxidation and no limitation for pI as criteria. The most optimal match for each spot was considered using higher coverage rate, more matched peptides, and higher score without limitations on the taxonomic category and protein mass. Zero missed cleavage by trypsin and lowest mass tolerance, i.e. ± 50 ppm, were considered for most of the proteins. A few bands were searched with the following parameters to find the best match: two missed cut cleavages, limited to the "mammal" category, and/or a set ± 50% of total molecular mass. We consistently used multiple parameters such as low miss cut, low ppm, and first methionine oxidation in our searches to obtain reliably matched proteins. Identified proteins (i.e., Sp1, TFIIB, cdk9, Tat, and BRG1) were confirmed by Western blot analysis. Unless stated specifically, all data bases and tools used for bioinformatics analysis were from the following public websites: 
siRNA analysis
Oligonucleotides were designed and synthesized using the OligoEngine website [109] and the accession number for BRG1. Five oligonucleotides (see below), which span the 5' end, middle, and 3' end of the BRG1 mRNA, were chosen. The most optimal sequences had a GC content between 30% and 70%. HIV-1 infected cell lines were treated with TNF-α for 2 h. A mixture of the five oligonucleotides was electroporated into the cells, and HIV-1 replication was monitored by p24 Gag enzyme-linked immunosorbent assay (ELISA). The sequences of oligonu-
